Mereo BioPharma Group plc - Ordinary Shares (MREO)

CUSIP: 589492107

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / Ordinary Shares
Shares outstanding
795,765,179
Total 13F shares
90,226,943
Share change
+33,088,323
Total reported value
$304,106,740
Put/Call ratio
120%
Price per share
$3.37
Number of holders
64
Value change
+$110,829,354
Number of buys
46
Number of sells
17

Security key

589492107

Report period

Q1 2021

Institutions

64

Top holders

10

Top shareholders of MREO - Mereo BioPharma Group plc - Ordinary Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Boxer Capital, LLC
13F
Company
0.78%
6,226,673
$22,291,000 31 Dec 2020
13F
BAKER BROS. ADVISORS LP
13F
Company
0.76%
6,030,293
$21,588,000 31 Dec 2020
13F
Vivo Capital, LLC
13F
Company
0.53%
4,220,938
$15,111,000 31 Dec 2020
13F
CITADEL ADVISORS LLC
13F
Company
0.52%
4,115,455
$14,733,000 31 Dec 2020
13F
HHLR ADVISORS, LTD.
13F
Company
0.37%
2,976,121
$10,655,000 31 Dec 2020
13F
SUVRETTA CAPITAL MANAGEMENT, LLC
13F
Company
0.35%
2,748,999
$9,841,000 31 Dec 2020
13F
ALKEON CAPITAL MANAGEMENT LLC
13F
Company
0.24%
1,935,600
$6,929,000 31 Dec 2020
13F
Commodore Capital LP
13F
Company
0.23%
1,854,278
$6,638,000 31 Dec 2020
13F
Rubric Capital Management LP
13F
Company
0.23%
1,853,417
$6,635,000 31 Dec 2020
13F
Holocene Advisors, LP
13F
Company
0.22%
1,714,932
$6,139,000 31 Dec 2020
13F
SCHRODER INVESTMENT MANAGEMENT GROUP
13F
Company
0.2%
1,569,174
$5,618,000 31 Dec 2020
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.15%
1,158,000
$4,145,000 31 Dec 2020
13F
Ikarian Capital, LLC
13F
Company
0.14%
1,146,308
$416,000 31 Dec 2020
13F
JANUS HENDERSON GROUP PLC
13F
Company
0.14%
1,124,678
$3,998,000 31 Dec 2020
13F
Asymmetry Capital Management, L.P.
13F
Company
0.09%
739,812
$2,649,000 31 Dec 2020
13F
Tri Locum Partners LP
13F
Company
0.09%
728,710
$2,609,000 31 Dec 2020
13F
DAFNA Capital Management LLC
13F
Company
0.08%
668,148
$2,392,000 31 Dec 2020
13F
Affinity Asset Advisors, LLC
13F
Company
0.08%
625,000
$2,238,000 31 Dec 2020
13F
PRIMECAP MANAGEMENT CO/CA/
13F
Company
0.06%
489,100
$1,751,000 31 Dec 2020
13F
Monashee Investment Management LLC
13F
Company
0.06%
461,639
$1,653,000 31 Dec 2020
13F
J. Goldman & Co LP
13F
Company
0.06%
460,051
$1,647,000 31 Dec 2020
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.05%
359,200
$1,286,000 31 Dec 2020
13F
SILVERARC CAPITAL MANAGEMENT, LLC
13F
Company
0.04%
280,000
$1,002,000 31 Dec 2020
13F
Delphi Management Partners VIII, L.L.C.
13F
Company
0.03%
256,734
$919,000 31 Dec 2020
13F
Shay Capital LLC
13F
Company
0.02%
165,811
$594,000 31 Dec 2020
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.02%
161,180
$577,000 31 Dec 2020
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
0.02%
128,048
$458,000 31 Dec 2020
13F
Virtu Financial LLC
13F
Company
0.01%
59,966
$215,000 31 Dec 2020
13F
HSBC HOLDINGS PLC
13F
Company
0.01%
58,217
$211,000 31 Dec 2020
13F
PRELUDE CAPITAL MANAGEMENT, LLC
13F
Company
0.01%
52,521
$188,000 31 Dec 2020
13F
JANE STREET GROUP, LLC
13F
Company
0%
23,038
$82,000 31 Dec 2020
13F
Northeast Financial Consultants Inc
13F
Company
0%
16,667
$60,000 31 Dec 2020
13F
CSS LLC/IL
13F
Company
0%
14,735
$53,000 31 Dec 2020
13F
Wealthspire Advisors, LLC
13F
Company
0%
14,276
$51,000 31 Dec 2020
13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC
13F
Company
0%
11,200
$40,000 31 Dec 2020
13F
Lindbrook Capital, LLC
13F
Company
0%
5,000
$18,000 31 Dec 2020
13F
UBS Group AG
13F
Company
0%
4,614
$17,000 31 Dec 2020
13F
MORGAN STANLEY
13F
Company
0%
4,100
$15,000 31 Dec 2020
13F
ROYAL BANK OF CANADA
13F
Company
0%
2,000
$7,000 31 Dec 2020
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
1,655
$6,000 31 Dec 2020
13F
SIT INVESTMENT ASSOCIATES INC
13F
Company
0%
970
$3,000 31 Dec 2020
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
410
$1,000 31 Dec 2020
13F
Rockefeller Capital Management L.P.
13F
Company
0%
358
$1,000 31 Dec 2020
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
230
$1,000 31 Dec 2020
13F
RBC Europe Ltd
13F
Company
0%
184
$659 31 Dec 2020
13F

Institutional Holders of Mereo BioPharma Group plc - Ordinary Shares (MREO) as of Q1 2021

As of 31 Mar 2021, Mereo BioPharma Group plc - Ordinary Shares (MREO) was held by 64 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 90,226,943 shares. The largest 10 holders included ORBIMED ADVISORS LLC, Point72 Asset Management, L.P., BAKER BROS. ADVISORS LP, SUVRETTA CAPITAL MANAGEMENT, LLC, BOXER CAPITAL, LLC, PERCEPTIVE ADVISORS LLC, Rock Springs Capital Management LP, Vivo Capital, LLC, HILLHOUSE CAPITAL ADVISORS, LTD., and Rubric Capital Management LP. This page lists 64 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders
44
Q1 2021 holders
64
Holder diff
20
Investor Q4 2020 Shares Q1 2021 Shares Share Diff Share Chg % Q4 2020 Value $ Q1 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .